← Human Trials & Peer-Reviewed Studies
The Effect of Erector Spinae Plane Block With and Without Addition of Magnesium on Relief of Pain from Post-herpetic Neuralgia.
Plain-language guide to PMID 35901476 (2022): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 75 patients.
Key Facts
- PMID
- 35901476
- Journal
- Pain physician
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Ahmed SA et al. (4 authors)
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The best tool for management of postherpetic neuralgia (PHN) is a matter of debate.
The study was limited by being a singlecenter study, using a single-level injection, and using a single volume of local anesthetic mixture.
Who Took Part
The abstract describes 75 patients taking part.
A total of 75 patients with PHN were included in the study.
Patients were randomly divided into 3 equal groups.
How the Study Was Run
In design terms this was a randomized and double-blind study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Neither the patients nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
All patients received standard medical care.
The pain score, the consumption of pregabalin and acetaminophen, the incidence of complications, and the patient's satisfaction were measured and recorded.
What Was Measured
The study was limited by being a singlecenter study, using a single-level injection, and using a single volume of local anesthetic mixture.
The subject headings attached to it are Acetaminophen, Analgesics, Bupivacaine, Magnesium, Magnesium Sulfate, Nerve Block and Neuralgia, Postherpetic.
Author keywords: erector spinae plane, lumbar, pain score, paracetamol, pregabalin and thoracic.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 75 patients.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2022 (Pain physician), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.